Cogent Biosciences, Inc. (COGT) › Net IncomeCogent Biosciences, Inc. (COGT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$25.49M2018: -$34.53M2019: -$31.83M2020: -$74.81M2021: -$72.27M2022: -$140.24M2023: -$192.41M2024: -$255.86M2025: -$328.94M-$328.94M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$328.94M-28.6%2024-$255.86M-33.0%2023-$192.41M-37.2%2022-$140.24M-94.0%2021-$72.27M+3.4%2020-$74.81M-135.0%2019-$31.83M+7.8%2018-$34.53M-35.5%2017-$25.49M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share